Back

JNJ Stock

Live symbol workspace

JNJ market intelligence

Chart context, AI evidence, sentiment, related news, and verified outcome history are grouped into one asset dossier.

Current $243.04
Trend Flat
Sentiment Neutral

Price Chart

📈
Loading chart for JNJ...
Powered by TradingView
{# Only render the live technical grid when the AI analysis carries real, non-placeholder data. Sentinel payloads (data_status error/collecting, current_price 0) are handled by the Asset Intelligence Dossier below, which degrades to a calm branded empty state instead of "0%" widgets. #}

Detailed Market Analysis

Key Levels

Support
$230.89
Resistance
$255.19

Volume & Momentum

Volume
Normal
1.0x avg
Momentum
0%
Weak

Technical Context

Current price
$243.04
RSI context
50

Market Sentiment

50
Neutral

Stock Metrics

Daily Vol
0%
VIX Est
20
Weekly
0%

Asset Intelligence Dossier

Over the last 30 days, AI sentiment for JNJ skewed neutral (5 of 6 scored calls).

Provider track record

Not enough scored provider calls yet for this asset.

Confidence trend

31%
▼ 2.9 pts vs previous week
Avg confidence across 40 calls in the last 7 days

What sources say

Neutral 5 articles
Ebola Crisis Exposes Congo's Fragile Health System
Which Pharmaceutical ETF Is Better, VanEck's PPH or Invesco's PJP?
Why Is JNJ Stock Defying The Market’s Daily Mood Swings?
Bearish 1 article
Stock Market Today, June 18: Pfizer Falls as CFO Transition Tests Confidence in 2026 Outlook

Insider Trading

Insider Role Date Type Value
Wengel Kathryn E EVP, Chief … Jun 11 '26 Option Exercise 1156700.0
Wengel Kathryn E EVP, Chief … Jun 11 '26 Sale 2411500.0
Wengel Kathryn E Officer Jun 11 '26 Proposed Sale 2401539.0
REED JOHN C EVP, Innovative … May 01 '26 Option Exercise 0.0
Decker Robert J VP Corporate … Feb 27 '26 Option Exercise 471355.0
Decker Robert J VP Corporate … Feb 27 '26 Sale 1010070.0
Decker Robert J Officer Feb 27 '26 Proposed Sale 1010070.0
Schmid Timothy EVP, WW … Feb 20 '26 Sale 324763.0
Schmid Timothy Officer Feb 20 '26 Proposed Sale 324763.0
Swanson James D. EVP, CIO Feb 13 '26 Option Exercise 6824543.0

Source: FinViz — Data may be delayed

Technical Observations

Refreshing technical observations from FinViz...

JNJ News Intelligence (24 articles)

AI-curated news influencing JNJ price, sentiment, and trend

Explore All JNJ News with AI Analysis
Economy
1 month, 3 weeks ago

3 Healthcare Stocks with Open Questions

Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently …

Impact on JNJ: The healthcare sector's underperformance may lead to a rotation out of healthcare …
The healthcare sector has underperformed the S&P 500 by 2.3 percentage points over the past … High (70%)
View full analysis →
Economy ⭐ FEATURED
1 month, 3 weeks ago

S&P 500, Nasdaq boosted by chips to record closing highs

STORY: The S&P 500 and the Nasdaq gained ground on Wednesday with a boost from artificial intelligence-related tech shares.The Dow …

Impact on JNJ: The surge in producer prices may lead to a rate hike if …
The S&P 500 and Nasdaq reached record closing highs, driven by artificial intelligence-related tech shares, … High (80%)
View full analysis →
Stocks
2 months, 1 week ago

Frothy, but not like 1999: This new valuation indicator has stocks beating inflation

Shiller CAPE ratio predicts a lost decade, but this superior model shows a path to positive real returns.

Impact on JNJ: The introduction of this new valuation indicator could lead to a shift …
A new valuation indicator suggests stocks may outperform inflation, contradicting the Shiller CAPE ratio's prediction … High (70%)
View full analysis →
Economy
2 months, 2 weeks ago

3 Vanguard ETFs Crushing the S&P 500 in 2026

The rotation we've seen within U.S. equities this year has created a new class of winners outside of tech and …

Impact on JNJ: The outperformance of these Vanguard ETFs may lead to increased capital flows …
Three Vanguard ETFs are outperforming the S&P 500 in 2026, indicating a shift in market … High (70%)
View full analysis →
Economy
2 months, 3 weeks ago

Johnson & Johnson (JNJ) is Gaining from Its Strong Innovative Medicine Growth

Mar Vista Investment Partners, LLC, an investment management company, released its “Mar Vista U.S. Quality Strategy” first-quarter 2026 investor letter. …

Impact on JNJ: Neutral market sentiment indicated
FinBERT analysis of financial text showing neutral sentiment with 94.1% confidence. High (94%)
View full analysis →
🤖

AI Analysis

Multi-Provider AI Analysis

Neutral

AI Summary

Loading...

Confidence
0%
AI Model Multi-Provider AI Analysis